Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-56.36	28.20	64.63
Graham Fair Price	23.91	3.70	2.99
PEG	-310.65	-0.07	-0.02
Price/Book	-4.09	1.57	1.63
Price/Cash Flow	11297.94	2335.98	20.49
Prices/Earnings	-38.76	18.03	-29.44
Price/Sales	-1.21	3.10	3.14
Price/FCF	11297.94	2335.98	20.49
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	370.33	0.32	0.07
Operating Margin	54.99	0.08	0.05
ROA	60.32	0.01	< 0.005
ROE	-0.01	0.02	56.61
ROIC	0.01	0.02	47.73
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	-0.33	74.85
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.92	0.54	-41.50
EPS QOQ	-17.55	2.62	-85.09
FCF QOQ	1.45	-0.99	-31.55
Revenue QOQ	0.14	< 0.005	-93.75
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	61.97	80.43	29.79
Days Sales Outstanding (DSO)	52.23	60.29	15.42
Inventory Turnover	1.45	1.12	-22.95
Debt/Capitalization	0.34	0.32	-5.94
Quick Ratio	0.60	0.92	52.43
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.35	5.30	-0.98
Cash	0.96	0.71	-26.30
Capex	-0.25	-0.23	8.04
Free Cash Flow	0.43	< 0.005	-99.17
Revenue	2.79	2.68	-3.87
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.10	1.65	50.22
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.02	5.30	-55.89
Naive Interpretation	Member

06 - Financial Health · Weak

Rating